Rchr
J-GLOBAL ID:200901018743860629   Update date: Nov. 05, 2024

Ishigaki Hirohito

イシガキ ヒロヒト | Ishigaki Hirohito
Affiliation and department:
Job title: Associate Professors
Research field  (4): Internal medicine - General ,  Immunology ,  Immunology ,  Experimental pathology
Research keywords  (6): immunology ,  internal medicine ,  pathology ,  cancer immunology ,  regenerative medicine ,  iPSCs
Research theme for competitive and other funds  (11):
  • 2024 - 2027 霊長類モデルを用いた末梢血IL-6産生細胞の特徴と免疫記憶に与える影響の解析
  • 2019 - 2022 Study on molecular mechanism of collagen-induced arthritis in cynomolgus monkeys
  • 2019 - 2022 Development of diagnosis and therapy for aging using a nonhuman primate model of premature aging
  • 2019 - 2022 Mechanism of plasma membrane expression of endoplasmic reticulum chaperone proteins
  • 2017 - 2020 Clinicopathological and molecular pathological differentiation between fundic gland polyp and fundic gland polyp-like lesion of the stomach
Show all
Papers (83):
  • Hirohito Ishigaki, Takayoshi Yamauchi, Mark D. Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito. Data from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. 2024
  • Hirohito Ishigaki, Takayoshi Yamauchi, Mark D. Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito. Supplementary Figure 2 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. 2024
  • Hirohito Ishigaki, Takayoshi Yamauchi, Mark D. Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito. Supplementary Table 3 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. 2024
  • Hirohito Ishigaki, Takayoshi Yamauchi, Mark D. Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito. Supplementary Figure 4 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. 2024
  • Hirohito Ishigaki, Takayoshi Yamauchi, Mark D. Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito. Supplementary Table 1 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. 2024
more...
MISC (120):
  • 石垣 宏仁. 動物MHC研究の新展開:医学や種の保存への応用を目指して カニクイザルCIAモデルの特徴とCIA感受性MHC-DRBアレルの同定. MHC: Major Histocompatibility Complex. 2023. 30. 2Suppl. 49-49
  • 大村 寧, 高木 彩乃, 小杉 和希, 鍬田 菜摘, 西村 公宏, 石垣 宏仁, 杉原 洋行. 劇症1型糖尿病様の経過で突然死し,病理解剖を施行した一症例. 糖尿病. 2023. 66. 4. 308-308
  • 塩原 正規, 仲山 美沙子, 石垣 宏仁, 伊藤 靖. インフルエンザ不活化全粒子ワクチンはB細胞の体細胞高頻度突然変異を誘導する。. 日本病理学会会誌. 2023. 112. 1. 242-242
  • 仲山 美沙子, 北川 直子, 石垣 宏仁, Nguyen Thanh Cong, 石田 英明, 鈴木 紗織, 小笠原 一誠, 伊藤 靖. サルにおけるH5N1不活化全粒子ワクチン接種5年後の肺炎予防効果. 日本病理学会会誌. 2023. 112. 1. 242-242
  • 森河 友里, 仲山 美沙子, 笹村 孝子, 石垣 宏仁, 伊藤 靖. 慢性呼吸器疾患患者由来の気道オルガノイドにおけるインフルエンザおよび新型コロナウイルス受容体の発現. 日本病理学会会誌. 2023. 112. 1. 382-382
more...
Patents (8):
Education (2):
  • 2003 - 2006 Shiga University of Medical Science Faculty of Medicine Ph.D. course student
  • 1994 - 2000 Shiga University of Medical Science Faculty of Medicine
Professional career (1):
  • 医学博士 (滋賀医科大学)
Work history (7):
  • 2021/10 - 現在 滋賀医科大学 病理学講座 疾患制御病態学部問 准教授
  • 2022/10 - 2023/03 University of Southern California Department of Surgery Post-doctral fellow
  • 2013/04 - 2021/09 Shiga University of Medical Science, Department of Pathology Branch of Pathology and Disease Regulation lecturer
  • 2008/01 - 2013/03 Departoment of Pathology Branch of Pathology and Disease Regulation assistant professor
  • 2006/04 - 2007/12 Shiga University of Medical Science, Department of Pathology Branch of Pathology and Disease Regulation project assistant professor
Show all
Association Membership(s) (7):
Japanese association of cancer immunology ,  JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE SOCIETY FOR IMMUNOLOGY ,  THE JAPANESE SOCIETY OF PATHOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page